Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
Saved in:
| Main Authors: | Shane M Devlin, Brian Bressler, Charles N Bernstein, Richard N Fedorak, Alain Bitton, Harminder Singh, Brian G Feagan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2013/327120 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subsequent Entry Biologics – Opportunities and Challenges
by: Subrata Ghosh
Published: (2013-01-01) -
Canadian Association of Gastroenterology Position Statement Regarding the Use of Thiopurines for the Treatment of Inflammatory Bowel Disease
by: John K Marshall, et al.
Published: (2014-01-01) -
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
by: Angela Rocchi, et al.
Published: (2012-01-01) -
Molecular Biology of Rotavirus Entry and Replication
by: Marie Christine Ruiz, et al.
Published: (2009-01-01) -
Canadian Association of Gastroenterology Position Statement on Screening Individuals at Average Risk for Developing Colorectal Cancer: 2010
by: Desmond J Leddin, et al.
Published: (2010-01-01)